What does Pharmacie BODARD do?

Pharmacie BODARD is a pharmacy in Marche-en-Famenne. Private Limited, started on 21 April 1982, 2 establishments.

What is the address of Pharmacie BODARD?

The registered office of Pharmacie BODARD is located at Marche, Chaussée de Liège 80, 6900 Marche-en-Famenne.

Is Pharmacie BODARD still active?

Yes. According to the CBE (29 October 2026) Pharmacie BODARD is active, legal situation “Normale toestand”, started on 21 April 1982.

Is Pharmacie BODARD registered on Peppol?

Yes, Pharmacie BODARD is registered on the Peppol network with ID 0208:0422632265.

What is the enterprise number of Pharmacie BODARD?

The enterprise number of Pharmacie BODARD is BE0422632265.

When was Pharmacie BODARD founded?

Pharmacie BODARD was founded on 21 April 1982.

Who are the directors of Pharmacie BODARD?

According to the 2025 annual accounts, the directors of Pharmacie BODARD are: Joëlle Denis, Olivier Groffy.

Is Pharmacie BODARD a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 April 1982; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account; 2 establishments in the CBE.

How much profit did Pharmacie BODARD make in 2025?

Pharmacie BODARD recorded a loss after taxes of € 122,242 in financial year 2025.

What is the revenue of Pharmacie BODARD?

As a small company, Pharmacie BODARD is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 439,338.

How much does an employee at Pharmacie BODARD earn?

The average wage cost per full-time employee at Pharmacie BODARD was € 82,900 in 2025: staff costs of € 414,481 for 5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Pharmacie BODARD have?

According to the 2025 annual accounts, Pharmacie BODARD has 5 full-time equivalents (FTE).

Pharmacie BODARD (Private Limited) - Marche-en-Famenne

Dossier Pharmacie BODARD, printed on 29 October 2026 from databakkes.be/en/0422632265/pharmacie-bodard. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 4 of the last 4 fiscal years.
Two loss years in a row NBB

Negative result in 2024 and 2025.
Tight liquidity NBB

Cash and receivables cover 10 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Pharmacie BODARD from Marche-en-Famenne, company number BE0422632265, closed financial year 2025 with a result of € -122,242 after tax. For that financial year Pharmacie BODARD recorded a gross margin of € 439,338 and equity of € -745,658. Compared with financial year 2024, the result moved from € -161,333 to € -122,242. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 20, 2026.

What it is worth Caution

€ -745,658

▼ € 122,242 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -122,242

▲ 24 % less loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 11,447

▼ 19% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -764,250.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 414,481

▲ 2% vs 2024

€ 82,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 48,704

▼ 30% vs 2024

Of which on lease € 45,438.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 315,182

▼ 23% vs 2024

€ 99,426 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 122,076

▼ 3% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 40,702

▼ 5% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 409,746 Gross margin 2022: € 409,746 First fiscal year in the series	€ 356,373 Gross margin 2023: € 356,373 ▼ 13% vs 2022 (€ 409,746) Unfavourable step	€ 399,174 Gross margin 2024: € 399,174 ▲ 12% vs 2023 (€ 356,373) Favourable step	€ 439,338 Gross margin 2025: € 439,338 ▲ 10% vs 2024 (€ 399,174) Favourable step	▲ 10%
Profit after taxes	€ 10,576 Profit after taxes 2022: € 10,576 First fiscal year in the series	€ -123,900 Profit after taxes 2023: € -123,900 ▼ € 134,476 vs 2022 (€ 10,576) Unfavourable step	€ -161,333 Profit after taxes 2024: € -161,333 ▼ € 37,433 vs 2023 (€ -123,900) Unfavourable step	€ -122,242 Profit after taxes 2025: € -122,242 ▲ € 39,091 vs 2024 (€ -161,333) Favourable step	▲ € 39,091
Equity	€ -338,183 Equity 2022: € -338,183 First fiscal year in the series	€ -462,083 Equity 2023: € -462,083 ▼ € 123,900 vs 2022 (€ -338,183) Unfavourable step	€ -623,416 Equity 2024: € -623,416 ▼ € 161,333 vs 2023 (€ -462,083) Unfavourable step	€ -745,658 Equity 2025: € -745,658 ▼ € 122,242 vs 2024 (€ -623,416) Unfavourable step	▼ € 122,242
Total debts	€ 1,330,279 Total debts 2022: € 1,330,279 First fiscal year in the series	€ 1,568,275 Total debts 2023: € 1,568,275 ▲ 18% vs 2022 (€ 1,330,279) Unfavourable step	€ 1,611,800 Total debts 2024: € 1,611,800 ▲ 3% vs 2023 (€ 1,568,275) Unfavourable step	€ 1,580,617 Total debts 2025: € 1,580,617 ▼ 2% vs 2024 (€ 1,611,800) Favourable step	▼ 2%
Cash	€ 43,213 Cash 2022: € 43,213 First fiscal year in the series	€ 25,685 Cash 2023: € 25,685 ▼ 41% vs 2022 (€ 43,213) Unfavourable step	€ 14,159 Cash 2024: € 14,159 ▼ 45% vs 2023 (€ 25,685) Unfavourable step	€ 11,447 Cash 2025: € 11,447 ▼ 19% vs 2024 (€ 14,159) Unfavourable step	▼ 19%
Retained profit	€ -356,775 Retained profit 2022: € -356,775 First fiscal year in the series	€ -480,675 Retained profit 2023: € -480,675 ▼ € 123,900 vs 2022 (€ -356,775) Unfavourable step	€ -642,008 Retained profit 2024: € -642,008 ▼ € 161,333 vs 2023 (€ -480,675) Unfavourable step	€ -764,250 Retained profit 2025: € -764,250 ▼ € 122,242 vs 2024 (€ -642,008) Unfavourable step	▼ € 122,242
Bank debt	€ 367,969 Bank debt 2022: € 367,969 First fiscal year in the series	€ 512,049 Bank debt 2023: € 512,049 ▲ 39% vs 2022 (€ 367,969) Unfavourable step	€ 407,137 Bank debt 2024: € 407,137 ▼ 20% vs 2023 (€ 512,049) Favourable step	€ 315,182 Bank debt 2025: € 315,182 ▼ 23% vs 2024 (€ 407,137) Favourable step	▼ 23%
Balance sheet total	€ 992,095 Balance sheet total 2022: € 992,095 First fiscal year in the series	€ 1,106,192 Balance sheet total 2023: € 1,106,192 ▲ 12% vs 2022 (€ 992,095) Unchanged	€ 988,384 Balance sheet total 2024: € 988,384 ▼ 11% vs 2023 (€ 1,106,192) Unchanged	€ 834,959 Balance sheet total 2025: € 834,959 ▼ 16% vs 2024 (€ 988,384) Unchanged	▼ 16%
Employees (FTE)	4.6 Employees (FTE) 2022: 4.6 First fiscal year in the series	5 Employees (FTE) 2023: 5 ▲ 0.4 vs 2022 (4.6) Unchanged	5 Employees (FTE) 2024: 5 Unchanged (5) Unchanged	5 Employees (FTE) 2025: 5 Unchanged (5) Unchanged

Key figures of Pharmacie BODARD, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Pharmacie BODARD?

What happened at Pharmacie BODARD in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 20, 2026 New annual accounts for financial year 2025: loss of € 122,242. filed late Source: NBB ↗
Aug 28, 2023 New establishment in Tintigny. KBO
May 1, 1982 New establishment in Marche-en-Famenne. KBO
Apr 21, 1982 Start of the company according to the CBE. KBO

In short

From € 10,576 profit in 2022 to € 122,242 loss in 2025.

Paid € 2,114 in corporate taxes since 2022.

Best year ever: 2022, with € 10,576 profit.

On average € 87,900 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

ExpansionPharma 100%

The stake of ExpansionPharma comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Pharmacie BODARD

Behind Pharmacie BODARD are Joëlle Denis and Olivier Groffy. The shares are held by ExpansionPharma (100%).

Directors

According to the 2025 annual accounts

Joëlle Denis

Director

Also active at: AKT - CCI Luxembourg Belge, Pharmacie Forthomme, PHARMADEFI, PHARMACIE HITTELET, L.O.J'M, PHARMALORRAINE, ExpansionPharma, DYNAMIC PHARMA +1 more

Olivier Groffy

Director

Also active at: Pharmacie Forthomme, PHARMADEFI, PHARMACIE HITTELET, L.O.J'M, PHARMALORRAINE, ExpansionPharma, DYNAMIC PHARMA, delta SUD PHARMA

Shareholders

ExpansionPharma

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Marche, Chaussée de Liège 80

6900 Marche-en-Famenne

2.348.629.524

Rue de France,Tintigny 50

6730 Tintigny

Active since 28 August 2023

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0422.632.265

VAT number

BE 0422.632.265

Registered office

Marche, Chaussée de Liège 80, 6900 Marche-en-Famenne

Names & denominations

Pharmacie BODARD

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

21 April 1982

Peppol

Active · Active since 26 Jan 2026

Contact

[email protected] +3284311820

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Detailhandel in cosmetica en toiletartikelen

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in medische en orthopedische artikelen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

Pharmacie BODARD

Warning lights

Financials

What happened to Pharmacie BODARD?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions